X Li1, J F Zhang, M Q Lu, Y Yang, C Xu, H Li, G S Wang, C J Cai, G H Chen. 1. Department of Liver Transplantation, The Third Affiliated Hospital of Sun Yat-sen University, 600 Tianhe Road, Guangzhou, Guangdong Province 510630, China.
Abstract
BACKGROUND: Cellular apoptosis plays an important role in ischemia-reperfusion (I/R) injury during organ transplantation. Synthetic small interference RNA (siRNA) targeting apoptotic receptor Fas has proven effective to protect mice against hepatitis and renal I/R injury. The objective of this study is to investigate the silencing impact of Fas siRNA to alleviate I/R injury in rat liver transplantation. MATERIALS AND METHODS: Rat hepatocytes (BRL cells) were transfected with three pairs of synthesized Fas siRNA; cells untreated and treated with GFP siRNA were taken as blank and siRNA control. The most effective Fas siRNA was chosen for in vivo experiments. Syngeneic orthotopic liver transplantation was performed in Fas siRNA group, siRNA control group, and blank control group of Sprague-Dawley rats. There were 25 pairs of rats in each group. siRNA transfection of donor rats was done with hydrodynamic injection method 48 h before liver procurement. Blood and liver samples were collected for evaluation of serum ALT levels, Fas protein and mRNA expression, and apoptosis by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) staining, 1, 3, 6, 12, and 24 h after liver transplantation. RESULTS: Fas siRNA2, which inhibited Fas gene expression much more than other siRNAs, was chosen for in vivo experiment. The serum ALT levels of Fas siRNA group were much less than those of blank and siRNA control groups 1, 3, 6, 12, and 24 h after blood reperfusion, indicating diminishing ischemia-reperfusion injury. Donor livers in Fas siRNA group had substantially less cell apoptosis. The expression of Fas mRNA and protein was reduced dramatically in the Fas siRNA group compared with the other two groups. CONCLUSION: Fas-mediated apoptosis play an important role in I/R injury of rat liver transplantation. Silencing Fas by hydrodynamic injection of siRNA holds therapeutic promise to limit I/R injury.
BACKGROUND: Cellular apoptosis plays an important role in ischemia-reperfusion (I/R) injury during organ transplantation. Synthetic small interference RNA (siRNA) targeting apoptotic receptor Fas has proven effective to protect mice against hepatitis and renal I/R injury. The objective of this study is to investigate the silencing impact of Fas siRNA to alleviate I/R injury in rat liver transplantation. MATERIALS AND METHODS:Rat hepatocytes (BRL cells) were transfected with three pairs of synthesized Fas siRNA; cells untreated and treated with GFP siRNA were taken as blank and siRNA control. The most effective Fas siRNA was chosen for in vivo experiments. Syngeneic orthotopic liver transplantation was performed in Fas siRNA group, siRNA control group, and blank control group of Sprague-Dawley rats. There were 25 pairs of rats in each group. siRNA transfection of donorrats was done with hydrodynamic injection method 48 h before liver procurement. Blood and liver samples were collected for evaluation of serum ALT levels, Fas protein and mRNA expression, and apoptosis by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) staining, 1, 3, 6, 12, and 24 h after liver transplantation. RESULTS:Fas siRNA2, which inhibited Fas gene expression much more than other siRNAs, was chosen for in vivo experiment. The serum ALT levels of Fas siRNA group were much less than those of blank and siRNA control groups 1, 3, 6, 12, and 24 h after blood reperfusion, indicating diminishing ischemia-reperfusion injury. Donor livers in Fas siRNA group had substantially less cell apoptosis. The expression of Fas mRNA and protein was reduced dramatically in the Fas siRNA group compared with the other two groups. CONCLUSION:Fas-mediated apoptosis play an important role in I/R injury of rat liver transplantation. Silencing Fas by hydrodynamic injection of siRNA holds therapeutic promise to limit I/R injury.
Authors: G Feldmann; D Haouzi; A Moreau; A M Durand-Schneider; A Bringuier; A Berson; A Mansouri; D Fau; D Pessayre Journal: Hepatology Date: 2000-03 Impact factor: 17.425
Authors: Andrew C Hsieh; Ronghai Bo; Judith Manola; Francisca Vazquez; Olivia Bare; Anastasia Khvorova; Stephen Scaringe; William R Sellers Journal: Nucleic Acids Res Date: 2004-02-09 Impact factor: 16.971
Authors: Bibo Ke; Xiu-Da Shen; Charles R Lassman; Feng Gao; Masamichi Katori; Ronald W Busuttil; Jerzy W Kupiec-Weglinski Journal: Transplantation Date: 2003-04-27 Impact factor: 4.939
Authors: P Kossmehl; E Kurth; S Faramarzi; B Habighorst; M Shakibaei; M Wehland; R Kreutz; M Infanger; A H J Danser; J Grosse; M Paul; D Grimm Journal: Apoptosis Date: 2006-03 Impact factor: 4.677
Authors: Mohammed Al-Saeedi; Niels Steinebrunner; Hassan Kudsi; Niels Halama; Carolin Mogler; Markus W Büchler; Peter H Krammer; Peter Schemmer; Martina Müller Journal: Cell Death Dis Date: 2018-01-26 Impact factor: 8.469
Authors: Rui Miguel Martins; João Soeiro Teodoro; Emanuel Furtado; Anabela Pinto Rolo; Carlos Marques Palmeira; José Guilherme Tralhão Journal: Int J Med Sci Date: 2018-01-08 Impact factor: 3.738